DARA BioSciences, Inc.

8601 Six Forks Road, Suite 160
Raleigh, NC 27615 USA
Click for website

Research Sector

Summary Description Develops and commercializes pharmaceuticals for patients with cancer.

Management David J. Drutz, CEO & CMO; Christopher Clement, President & COO; David Tousley, Acting CFO; Ann A. Rosar, VP of Finance; David Benharris, VP of Sales, Marketing and Business Development; Michael Radomsky, VP of Technical Operations;

Click here for Financial Data
Keywords: oncology, breast cancer, radiology, pain management, support, cancer, oncology radiation, dysphagia, tamoxifen, hyaluronic acid, Bionect, Soltamox, Gelclair, CIPN, chemotherapy induced peripheral neuropathy, KRN5500


Updated: Mar. 22, 2016


DARA BioSciences is focused on development and commercialization of oncology treatment and supportive care products under a team of strong business leaders. DARA's structure results in success -- for ......view more

Products / Services

DARA increased its focus in oncology through its January 2012 acquisition of Oncogenerix, Inc., which held the exclusive U.S. marketing rights to Soltamox, a novel oral liquid formulation of tamoxife......view more